The size of the European Micro Guide Catheters Market is forecasted to grow at a prominent CAGR from 2021 to 2026.
The inactive lifestyle of the people inclined for cardiovascular or other related diseases is prone to various chronic ailments, and changes in the food habits are majorly propelling the growth rate of the European micro-guide catheters market. Low price and favorable reimbursement are some other significant factors impelling the growth of the market in the region. Growing demand for minimum invasive surgeries like assuring quick recovery, minimizing hospital stays, preventive bleeding, and reducing the hurdles post-surgery are some factors to accelerate the market growth in Europe.
Threat associated with catheter material and the high costs associated with the diagnosis and treatment of micro guide catheters used in the surgery process are majorly hindering the market growth in the European region.
This research report on the Europe Micro Guide Catheters Market has been segmented and sub-segmented into the following categories:
By Type:
By Therapeutic Area:
By Country:
Regional Analysis:
The micro guide catheter market in Europe is anticipated to have a promising market share in the region with a high CAGR rate from 2020 to 2025. Europe is likely to hold 40.0% of the share in the market. Factors like increasing incidences of cardiovascular and urological diseases are responsible for the growth of the market. Also, the availability of healthcare infrastructure and technology advancements in catheters is propelling the micro guide catheters market in the region.
The UK is leading the micro guide catheters market in Europe, followed by Germany. Factors like the rise in the senior citizen's population and growing micro guide catheters' applications are projected to accelerate the market. Healthcare expenses, enhancing healthcare infrastructure, and massive alertness among the patients are fuelling the growth rate of the market. Increasing the use of catheters, which assure security and efficacy in high-risk procedures, is anticipated to lead the market shares. Expanding the use of catheters, which assure security and effectiveness in high-risk procedures, is expected to lead the market shares.
The market is to have a quick growth rate in Germany in the foreseen years. The minimized time for healing assured using micro guide catheters is estimated to propel the development of the market in the region. Moreover, growing demand for developed and upgraded medical devices offering satisfactory results giving spur in the market growth of the area.
Prominent Companies dominating the Europe Micro Guide Catheters Market Profiled in the Report are Lake Region manufacturing Inc., Boston Scientific Corporation, Volcano Corporation, Micro Therapeutics Inc., LuMend Corporation, Terumo Europe N.V., Covidien AG, ASAHI INTECC Company Limited, and Merit Medical Systems Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Over-the-wire micro guide catheter
5.1.3 Flow directed micro guide catheter
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.1 Introduction
5.2.2 Neurovascular
5.2.3 Cardiovascular
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.1 Hospitals
5.3.2 Specialty Clinics
5.3.3 Ambulatory Surgery Centers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Therapeutic Area
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Therapeutic Area
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 LuMend Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Terumo Europe N.V.
8.3 Covidien AG
8.4 ASAHI INTECC Company Limited
8.5 Lake Region manufacturing Inc.
8.6 Boston Scientific Corporation
8.7 Volcano Corporation
8.8 Micro Therapeutics Inc
8.9 Merit Medical Systems Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
